The year in atherothrombosis.
Moreno
Pedro R
PR
Cardiovascular Institute, Mount Sinai School of Medicine, New York, New York, USA.
Fuster
Valentin
V
D058927:5-Lipoxygenase-Activating Proteins; D000818:Animals; D001161:Arteriosclerosis / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D002097:C-Reactive Protein / Q000032:analysis / Q000502:physiology; D019013:CD40 Antigens / Q000097:blood; D002352:Carrier Proteins / Q000502:physiology; D008076:Cholesterol, HDL / Q000097:blood; D003327:Coronary Disease / Q000097:blood / Q000453:epidemiology; D003952:Diagnostic Imaging; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D007249:Inflammation / Q000503:physiopathology; D008565:Membrane Proteins / Q000502:physiology; D009195:Peroxidase / Q000097:blood; D047492:Peroxisome Proliferator-Activated Receptors / Q000378:metabolism / Q000502:physiology; D018570:Risk Assessment; D013927:Thrombosis / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy
D058927:5-Lipoxygenase-Activating Proteins; C548592:ALOX5AP protein, human; D019013:CD40 Antigens; D002352:Carrier Proteins; D008076:Cholesterol, HDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008565:Membrane Proteins; D047492:Peroxisome Proliferator-Activated Receptors; D002097:C-Reactive Protein; D009195:Peroxidase